NM_001464.5:c.1561G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001464.5(ADAM2):c.1561G>A(p.Val521Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000997 in 1,605,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001464.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM2 | ENST00000265708.9 | c.1561G>A | p.Val521Ile | missense_variant | Exon 15 of 21 | 1 | NM_001464.5 | ENSP00000265708.4 | ||
ADAM2 | ENST00000347580.8 | c.1504G>A | p.Val502Ile | missense_variant | Exon 14 of 20 | 1 | ENSP00000343854.4 | |||
ADAM2 | ENST00000379853.6 | c.1183G>A | p.Val395Ile | missense_variant | Exon 11 of 17 | 1 | ENSP00000369182.2 | |||
ADAM2 | ENST00000521880.5 | c.1561G>A | p.Val521Ile | missense_variant | Exon 15 of 20 | 2 | ENSP00000429352.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 247840Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 133994
GnomAD4 exome AF: 0.00000895 AC: 13AN: 1452888Hom.: 0 Cov.: 29 AF XY: 0.0000125 AC XY: 9AN XY: 722716
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1561G>A (p.V521I) alteration is located in exon 15 (coding exon 15) of the ADAM2 gene. This alteration results from a G to A substitution at nucleotide position 1561, causing the valine (V) at amino acid position 521 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at